Chairman and Chief Executive Officer · GILEAD SCIENCES, INC. (GILD)

Daniel O'Day

A named executive officer of GILEAD SCIENCES in every fiscal year CompBrief holds from FY2019 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$28,437,198

FY2024: $23,689,392

1st of 5 named executive officers at Gilead Sciences by FY2025 total.

5 named officers on file for GILEAD SCIENCES, FY2025

See an example →

What this number hides

The filing gives the total. GILEAD SCIENCES’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed March 20, 2026 (DEF 14A).

Free

Get Daniel O'Day’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Daniel O'Day and every company like it: Velarion Intel, free for 3 days, no card →

Daniel O'Day compensation by year

GILEAD SCIENCES Summary Compensation Table · all 7 fiscal years held
In US dollars, as GILEAD SCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$1,267,692$1,702,885$1,650,000$1,691,154$1,740,962$1,771,201$1,795,192
Bonus$5,675,000$0$0$0$0$0$0
Stock awards$15,500,541$8,388,056$9,764,060$10,603,901$11,865,090$12,426,816$15,238,402
Option awards$3,000,002$3,125,041$3,375,004$3,750,014$3,749,966$4,125,011$4,500,060
Non-equity incentive$3,120,000$4,713,390$3,446,190$4,716,480$4,036,200$4,028,096$4,848,120
Pension and deferred compensation$0$0$0$0$0$0$0
All other$544,619$1,068,723$994,212$859,704$1,215,472$1,338,268$2,055,424
Total$29,107,854$18,998,095$19,229,466$21,621,253$22,607,690$23,689,392$28,437,198

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GILEAD SCIENCES, INC. DEF 14A filed March 20, 2026, accession 0001308179-26-000106, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GILEAD SCIENCES, INC. filed document, accession 0001308179-26-000106. Every figure is read from that document and cited to the page and table it appears in. Filed March 20, 2026.

$29.1M
$19.0M
$19.2M
$21.6M
$22.6M
$23.7M
$28.4M
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU85,580$10,504,089—
PSU58,550$7,186,427—
RSU38,396$4,712,725—
RSU38,395$4,712,602—
RSU32,292$3,963,510—
RSU30,887$3,791,070—
RSU27,739$3,404,626—
PSU25,755$3,161,169—
RSU24,709$3,032,789—
RSU21,441$2,631,699—
RSU21,226$2,605,285—
RSU14,741$1,809,310—

Per the Outstanding Equity Awards at Fiscal Year-End table in GILEAD SCIENCES, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 17 award rows shown.

GILEAD SCIENCES’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Daniel O'Day · this pageChairman and Chief Executive Officer$28,437,198
Dietmar BergerChief Medical Officer$13,922,878
Johanna MercierChief Commercial and Corporate Affairs Officer$9,300,643
Andrew DickinsonChief Financial Officer$8,765,616
Deborah TelmanFormer Executive Vice President, Corporate Affairs and General Counsel$5,004,669

Board service

GILEAD SCIENCES board · FY2021–FY2025

How this board is paid

Company policy: GILEAD SCIENCES pays directors a $75,000 cash retainer and $150,000 in Stock options and restricted stock units. As stated in GILEAD SCIENCES's FY2025 proxy.

The full GILEAD SCIENCES compensation record

free company brief

This page is one person within GILEAD SCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GILEAD SCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order GILEAD SCIENCES's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GILEAD SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order GILD

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Daniel O'Day's compensation dossier